Table 2.
Study | Calculation | Risk definition by calculation |
---|---|---|
Sokal et al. 19847 | Exp 0.0116 × (age − 43.4) + 0.0345 × (spleen − 7.51) + 0.188 × [(platelet count ÷ 700)2 − 0.563] + 0.0887 × (blast cells − 2.10) | Low risk: <0.8 |
Intermediate risk: 0.8-1.2 | ||
High risk: >1.2 | ||
Euro | 0.666 when age ≥50 y + (0.042 × spleen) + 1.0956 when platelet count >1500 × 109L + (0.0584 × blast cells) + 0.20399 when basophils >3% + (0.0413 × eosinophils) × 100 | Low risk: ≤780 |
Hasford et al. 19988 | Intermediate risk: 781-1480 | |
High risk: >1480 | ||
EUTOS | Spleen × 4 + basophils × 7 | Low risk: ≤87 |
Hasford et al. 20119 | High risk: >87 |
Age is given in years. Spleen is given in centimeters below the costal margin (maximum distance). Blast cells, eosinophils, and basophils are given in percent of peripheral blood differential. All values must be collected before any treatment. To calculate Sokal and Euro risk score, go to http://www.leukemia-net.org/content/leukemias/cml/cml_score/index_eng.html. To calculate EUTOS risk score, go to http://www.leukemia-net.org/content/leukemias/cml/eutos_score/index_eng.html.